Loading...
Market
How many countries will be conducting DBS trials for spinal cord injury by end of 2025?
2
Resolution / Starting Odds
1-2 countries • 25%
3-5 countries • 25%
6-10 countries • 25%
More than 10 countries • 25%
Global clinical trial registries and publications
Story
Swiss Researchers Restore Walking in Paraplegic Patients with Brain Stimulation Targeting Lateral Hypothalamus
Dec 2, 2024, 05:15 PM
Swiss researchers have achieved a groundbreaking medical advancement by enabling two paraplegic patients with partial spinal cord injuries to walk again using deep brain stimulation (DBS). The technique involves implanting electrodes in the lateral hypothalamus, a brain region not traditionally associated with movement, to stimulate neural activity. This innovative approach has shown promising results, allowing the patients to walk short distances, climb stairs, and improve lower limb movements. The study, published in Nature Medicine, also demonstrated similar recovery outcomes in preclinical models, including mice and rats. These findings highlight the potential of DBS as a transformative therapy for spinal cord injury rehabilitation.
View original story
Similar markets
United States • 25%
European Union • 25%
China • 25%
Other • 25%
0 countries • 25%
1-2 countries • 25%
3-4 countries • 25%
5 or more countries • 25%
Full mobility restoration in a patient • 25%
Widespread clinical trials • 25%
FDA approval • 25%
None of the above • 25%
Mayo Clinic • 25%
Johns Hopkins Hospital • 25%
Cleveland Clinic • 25%
Other • 25%
Yes • 50%
No • 50%
Japan • 25%
USA • 25%
EU • 25%
Other • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
11 to 15 countries • 25%
More than 15 countries • 25%
Less than 5 • 33%
5 to 10 • 33%
More than 10 • 33%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
0-1 • 25%
2-5 • 25%
6-10 • 25%
More than 10 • 25%